Search

Your search keyword '"Di Maro, Salvatore"' showing total 293 results

Search Constraints

Start Over You searched for: Author "Di Maro, Salvatore" Remove constraint Author: "Di Maro, Salvatore"
293 results on '"Di Maro, Salvatore"'

Search Results

1. Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients

4. Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites

5. Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification

10. The bright side of chemistry: Exploring synthetic peptide‐based anticancer vaccines.

14. Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment

15. Irreversible inhibition of TRF2TRFHrecruiting functions: a strategy to induce telomeric replication stress in cancer cells

17. Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides

20. CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists

21. A novel smaller β‐defensin‐derived peptide is active against multidrug‐resistant bacterial strains

22. First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment

23. Halting the Spread of Herpes Simplex Virus-1: The Discovery of an Effective Dual αvβ6/αvβ8 Integrin Ligand

24. Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening

25. Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors

26. Click-Chemistry (CuAAC) Trimerization of an αvβ₆ Integrin Targeting Ga-68-Peptide : Enhanced Contrast for in-Vivo PET Imaging of Human Lung Adenocarcinoma Xenografts

27. Disulfide Bond Replacement with 1,4‐ and 1,5‐Disubstituted [1,2,3]‐Triazole on C‐X‐C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences

28. Click‐Chemistry (CuAAC) Trimerization of an αvβ6 Integrin Targeting Ga‐68‐Peptide: Enhanced Contrast for in‐Vivo PET Imaging of Human Lung Adenocarcinoma Xenografts

29. Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase

30. HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein–Protein Interactions by NMR

31. Two novel SIRT1 activators, SCIC2 and SCIC2.1, enhance SIRT1-mediated effects in stress response and senescence

32. Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer

33. From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands

34. Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents

37. Intestinal Anti-Inflammatory Effect of a Peptide Derived from Gastrointestinal Digestion of Buffalo (Bubalus bubalis) Mozzarella Cheese

38. Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide

39. Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides

41. Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme

42. Von einer Helix zu einem kleinen Ring: Metadynamik-inspirierte, selektive Liganden für αvβ6-Integrin

43. From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands

44. Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors

45. Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells

46. Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)–Ligand Interactions on Living Cancer Cells

47. Structure–Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist

48. Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer

49. SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage

50. Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer

Catalog

Books, media, physical & digital resources